Eli Lilly (LLY) will likely not meet the demand for diabetes and weight loss drugs in 2024. The Eli Lilly CFO noted that increases in production capacity will take time. Eli Lilly is up over 150% year-over-year. Tune in to find out more about the stock market today.
#investing #trading #finance #stocks #global #equities #markets #stockmarket #stockmarkettoday #healthcare #elililly